Alexandra Toohey
@Baker Bros. Advisors Lp
Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.
Assets under management
The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CNTACentessa Pharmaceuticals Plc
| 0.21% | $19.623M 1.227M shares@ $15.99 avg price | Increased 123.45% |
PRAXPraxis Precision Medicines, Inc.
| 0.2% | $18.591M 323,105 shares@ $57.55 avg price | Increased 145.65% |
XNCRXencor, Inc.
| 0.14% | $13.482M 670,431 shares@ $20.11 avg price | Increased 22.92% |
DSGNDesign Therapeutics, Inc.
| 0.1% | $9.381M 1.744M shares@ $5.39 avg price | Increased 2.86% |
SKYESkye Bioscience, Inc.
| 0.06% | $5.609M 1.435M shares@ $3.92 avg price | Increased 186.93% |
GBIOGeneration Bio Co.
| 0.05% | $4.804M 1.945M shares@ $2.47 avg price | Increased 61.15% |